Boston Scientific…
USUSDBoston Scientific Corp (LSE:0HOY) — Medical Devices. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 5. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site Web
- bostonscientific.com
- Relations avec les Investisseurs
- bostonscientific.com/en-US/investor-relations-redirect.html
- Secteur
- Healthcare · Medical Devices
- Siège Social
- MARLBOROUGH, United States
- Direction
- Derniers Rapports
- Employés
- 59 000
- Fondée
- 1979
- IPO
- 1992-05-19
- Actions en Circulation
- 1.45 Md au 2026-07-30
- Flottant
- 1.44 Md
- Capitalisation Boursière
- 66.06 Md USD
- Initiés
- 0.25%
- Investisseurs Institutionnels
- 94.73%
- Secteur d'Activité (SIC)
- Surgical & Medical Instruments & Apparatus
- Forme Juridique
- XTIQ
- ISIN
- US1011371077
- LEI
- Y6ZDD9FP4P8JSSJMW954
- P/B
- 2.48
- FCF
- 3.63 Md USD
- Dette
- 10.9 Md USD2.9 ans de FCF
- Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
- Bénéfice Net
- NAV
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Bourses et Tickers
| Bourse | Ticker | Devise | Prix | Type |
|---|---|---|---|---|
| actions ordinaires | ||||
| US USA Stocks | BSX principale | USD | 42.69 +0.61% | actions ordinaires |
| LSE London Stock Exchange | 0HOY IOB | GBP | — | actions ordinaires |
| MI Borsa Italiana (Milan) | 1BSX secondaire | EUR | 38.565 +2.88% | actions ordinaires |
| VI Vienna Stock Exchange | BSXC secondaire | EUR | 39.785 +1.20% | actions ordinaires |
| XETRA Xetra | BSX secondaire | EUR | 39.825 +1.32% | actions ordinaires |
| certificat de dépôt | ||||
| SA B3 Sao Paulo | B1SX34 | BRL | 53.28 -3.58% | certificat de dépôt |
Actualités de Cette Semaine
Communiqués de presse du site de l'entreprise pour les investisseurs, mis à jour chaque jour. Les liens mènent au site de l'entreprise. Les titres sont dans la langue originale, comme sur le site web de l'entreprise.
| 28.10.2026 | Learn about our Q3 2026 earnings |
Principaux Actionnaires
| Détenteur | Participation | Actions | Date du Rapport |
|---|---|---|---|
| Blackrock Inc. | 8.95% | 129.68 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.7% | 97.09 M | 2026-06-30 |
| State Street Corporation | 4.84% | 70.11 M | 2026-06-30 |
| Primecap Management Comp… | 3.49% | 50.52 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.26% | 47.18 M | 2026-06-30 |
| FMR, LLC | 3.15% | 45.7 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.66% | 38.52 M | 2026-06-30 |
| Geode Capital Management… | 2.31% | 33.44 M | 2026-06-30 |
| VANGUARD CHESTER FUNDS-V… | 2.13% | 30.83 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.06% | 29.79 M | 2026-06-30 |
| Shaw D.E. & Co., Inc. | 1.76% | 25.46 M | 2026-06-30 |
| Massachusetts Financial… | 1.72% | 24.86 M | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.65% | 23.91 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.38% | 20.05 M | 2026-07-31 |
| Fidelity Concord Street… | 1.33% | 19.22 M | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.26% | 18.21 M | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 1.04% | 15.07 M | 2026-04-30 |
| Growth Fund of America | 0.78% | 11.25 M | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.74% | 10.68 M | 2026-08-31 |
| Fidelity Rutland Square… | 0.66% | 9.61 M | 2026-07-31 |
| MAHONEY MICHAEL F (Chief… | ≈0.11% | 1.61 M | 2026-08-03 |
| BRENNAN DANIEL J (Chief… | ≈0.02% | 225 808 | 2025-02-19 |
| FITZGERALD JOSEPH MICHAE… | ≈0.02% | 219 141 | 2026-02-13 |
| BUTCHER ARTHUR C (Office… | ≈0.01% | 77 115 | 2026-05-01 |
| SUNUNU JOHN E (Director) | ≈0% | 54 723 | 2025-05-08 |
| BROWN VANCE R (General C… | ≈0% | 54 244 | 2026-02-13 |
| WICHMANN DAVID S (Direct… | ≈0% | 45 382 | 2026-05-07 |
| MONSON JONATHAN R (Chief… | ≈0% | 39 063 | 2026-07-01 |
| LUDWIG EDWARD J. (Direct… | ≈0% | 30 359 | 2026-07-31 |
| CARRUTHERS WENDY (Office… | ≈0% | 29 308 | 2024-12-02 |
Connectez-vous avec Google